In partnership with the Skoll World Forum, Forbes features an interview with Kevin Reilly, former president of the vaccines and nutrition division of Wyeth Pharmaceuticals, who discusses the challenges of vaccine development and distribution. “Increasingly, I see pharmaceutical and vaccine manufacturers engaging in the dialogue about strengthening immunization and distribution systems to ensure vaccines get to where they are needed,” he said, according to the interview transcript. “Similarly, I see growing awareness among global health organizations about the difficult, multiyear process required to develop vaccines and how that process influences the price,” he added. Reilly also discusses the relationship among businesses, governments, civil society, and educational institutions in the development and delivery of medical products (Kanani, 8/6).